Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model	Sentinel Common Data Model	Methods, Data, & Tools	12/08/2020	Sentinel Common Data Model Methods, Data, & Tools 12/08/2020
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/introduction-signal-detection-analytics-core-sentinel	Introduction to the Signal Detection Analytics Core in the Sentinel Innovation Center	Sentinel Initiative Events	02/18/2021	Introduction to the Signal Detection Analytics Core in the Sentinel Innovation Center Sentinel Initiative Events 02/18/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/general-propensity-score-signal-identification-using-tree	A General Propensity Score for Signal Identification using Tree-Based Scan Statistics	Publications and Presentations	02/22/2021	A General Propensity Score for Signal Identification using Tree-Based Scan Statistics Publications and Presentations 02/22/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/serious-infections-among-immunocompromised-health-plan	Serious Infections among Immunocompromised Health Plan Members	Modular Programs	02/24/2021	Serious Infections among Immunocompromised Health Plan Members Modular Programs 02/24/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation	COVID-19 Pregnancy Study Implementation	Methods, Data, & Tools	02/24/2021	COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/advancing-scalable-natural-language-processing-approaches-unstructured	Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data	Ongoing Projects	02/26/2021	Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data Ongoing Projects 02/26/2021
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs	Data Quality Review and Characterization Programs	Methods, Data, & Tools	03/01/2021	Data Quality Review and Characterization Programs Methods, Data, & Tools 03/01/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/pregnancy-among-women-heart-failure-descriptive-analysis	Pregnancy among Women with Heart Failure: A Descriptive Analysis	Modular Programs	03/07/2021	Pregnancy among Women with Heart Failure: A Descriptive Analysis Modular Programs 03/07/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/characterization-mother-infant-linkage-sentinel	Characterization of Mother-Infant Linkage in the Sentinel Distributed Database	Modular Programs	03/11/2021	Characterization of Mother-Infant Linkage in the Sentinel Distributed Database Modular Programs 03/11/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/electronic-phenotyping-health-outcomes-interest-using-linked	Electronic Phenotyping of Health Outcomes of Interest Using a Linked Claims-Electronic Health Record Database: Findings from a Machine Learning Pilot Project	Publications and Presentations	03/12/2021	Electronic Phenotyping of Health Outcomes of Interest Using a Linked Claims-Electronic Health Record Database: Findings from a Machine Learning Pilot Project Publications and Presentations 03/12/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/counts-individuals-sentinel-distributed-database	Counts of Individuals in the Sentinel Distributed Database	Modular Programs	03/22/2021	Counts of Individuals in the Sentinel Distributed Database Modular Programs 03/22/2021
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	03/22/2021	Quarterly Newsletter Spotlight 03/22/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/venous-and-arterial-thromboembolism-among-new-users	Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis	Modular Programs	03/25/2021	Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis Modular Programs 03/25/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/angioedema-following-dipeptidyl-peptidase-iv-dpp-iv	Angioedema following Dipeptidyl Peptidase IV (DPP IV) Inhibitors and Angiotensin Converting Enzyme (ACE) Inhibitors Use: A Descriptive Analysis	Modular Programs	03/26/2021	Angioedema following Dipeptidyl Peptidase IV (DPP IV) Inhibitors and Angiotensin Converting Enzyme (ACE) Inhibitors Use: A Descriptive Analysis Modular Programs 03/26/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/lymphoma-risk-following-guselkumab-risankizumab-or	Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis	Modular Programs	03/30/2021	Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis Modular Programs 03/30/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/development-and-validation-real-world-mortality-variable	The Development and Validation of a Real-World Mortality Variable	Sentinel Initiative Events	03/30/2021	The Development and Validation of a Real-World Mortality Variable Sentinel Initiative Events 03/30/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-fdas	A COVID‐19‐Ready Public Health Surveillance System: The FDA's Sentinel System	Publications and Presentations	04/02/2021	A COVID‐19‐Ready Public Health Surveillance System: The FDA's Sentinel System Publications and Presentations 04/02/2021
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/routine-querying-system	Routine Querying System	Methods, Data, & Tools	04/14/2021	Routine Querying System Methods, Data, & Tools 04/14/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2016	Duration of Follow Up for New Molecular Entities Approved in 2016	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2016 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2014-and	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2010-2012	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2008-and	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2005-2006	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2011	Duration of Follow Up for New Molecular Entities Approved in 2011	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2011 Assessments 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/patterns-insulin-product-use-and-billing-codes	Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis	Modular Programs	04/16/2021	Patterns in Insulin Product Use and Billing Codes: A Descriptive Analysis Modular Programs 04/16/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/utilization-sacubitrilvalsartan-descriptive-analysis	Utilization of Sacubitril/Valsartan: A Descriptive Analysis	Modular Programs	04/19/2021	Utilization of Sacubitril/Valsartan: A Descriptive Analysis Modular Programs 04/19/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/angioedema-following-sacubitrilvalsartan-use-patients	Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis	Modular Programs	04/21/2021	Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Modular Programs 04/21/2021
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/angioedema-and-serious-angioedema-algorithms-defined	Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis"	Methods, Data, & Tools	04/21/2021	Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis" Methods, Data, & Tools 04/21/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/validity-icd-10-cm-diagnoses-identify-hospitalizations	Validity of ICD‐10‐CM Diagnoses to Identify Hospitalizations for Serious Infections Among Patients Treated With Biologic Therapies	Publications and Presentations	04/22/2021	Validity of ICD‐10‐CM Diagnoses to Identify Hospitalizations for Serious Infections Among Patients Treated With Biologic Therapies Publications and Presentations 04/22/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/advanced-approaches-evaluating-drug-safety-pregnancy	Advanced Approaches for Evaluating Drug Safety in Pregnancy	Sentinel Initiative Events	04/26/2021	Advanced Approaches for Evaluating Drug Safety in Pregnancy Sentinel Initiative Events 04/26/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/validation-electronic-algorithm-hodgkin-and-non-hodgkin-0	Validation of an Electronic Algorithm for Hodgkin and Non-Hodgkin Lymphoma in ICD-10-CM	Publications and Presentations	04/26/2021	Validation of an Electronic Algorithm for Hodgkin and Non-Hodgkin Lymphoma in ICD-10-CM Publications and Presentations 04/26/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies	Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database	Publications and Presentations	04/29/2021	Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database Publications and Presentations 04/29/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)	Methods, Data, & Tools	05/17/2021	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-data-visualization-project	Sentinel Data Visualization Project	Methods, Data, & Tools	05/17/2021	Sentinel Data Visualization Project Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/assessments/drugs/assessing-arias-ability-evaluate-safety-concern/ponvory-ponesimod	Assessment of ARIA Sufficiency: Ponvory (ponesimod)		05/17/2021	Assessment of ARIA Sufficiency: Ponvory (ponesimod) 05/17/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/demographic-characteristics-and-length-enrollment-individuals-enrolled	Demographic Characteristics and Length of Enrollment of the Individuals Enrolled over Time in the Sentinel Distributed Database	Methods, Data, & Tools	05/17/2021	Demographic Characteristics and Length of Enrollment of the Individuals Enrolled over Time in the Sentinel Distributed Database Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/assessments/drugs/assessing-arias-ability-evaluate-safety-concern/qelbree-viloxazine	Assessment of ARIA Sufficiency: Qelbree (viloxazine)	Assessments	05/18/2021	Assessment of ARIA Sufficiency: Qelbree (viloxazine) Assessments 05/18/2021
https://www.sentinelinitiative.org/assessments/drugs/individual-drug-queries/incidence-rate-severe-uterine-bleeding-among-new-users	Incidence Rate of Severe Uterine Bleeding Among New Users of Oral Anticoagulants: A Descriptive Analysis	Modular Programs	05/18/2021	Incidence Rate of Severe Uterine Bleeding Among New Users of Oral Anticoagulants: A Descriptive Analysis Modular Programs 05/18/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/improving-probabilistic-phenotyping-incident-outcomes-through-enhanced	Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing	Methods, Data, & Tools	05/20/2021	Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing Methods, Data, & Tools 05/20/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/risk-severe-abnormal-uterine-bleeding-associated-rivaroxaban	Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin	Publications and Presentations	05/20/2021	Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin Publications and Presentations 05/20/2021